Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients
Wei‐Ting Chang, Yu-Wen Lin, Chung‐Han Ho, Zhih‐Cherng Chen, Ping‐Yen Liu, Jhih-Yuan Shih
Topics & Concepts
DapagliflozinCardiotoxicityMedicineDiabetic cardiomyopathyDiabetes mellitusDoxorubicinCancerHeart failureEndocrinologyBreast cancerApoptosisInternal medicineCardiac function curvePharmacologyCardiomyopathyType 2 diabetesChemotherapyChemistryBiochemistryChemotherapy-induced cardiotoxicity and mitigationNeuroendocrine Tumor Research AdvancesMetabolism, Diabetes, and Cancer